glp-1 news today oct 2 2025 Products - Data Briefs - Number 537 How Supply and Demand for

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

DISCLOSURE AND DISCLAIMERS FDA Disclaimer

She said to me, 'There's no fat old people, only fat young people. If you don't get this stuff together you're not gonna be around." Q

My hope is that by explaining, and potentially convincing you of, their inevitability and the health inequity that will arise from delaying coverage, the conversation shifts away from should these be covered? to how do we ensure everyone who needs them is covered as soon as possible? How do we, collectively, best fight for patient access to these new revolutionary treatments

Additionally, some patients undergoing rapid weight loss with GLP-1 drugs have shown signs of muscle and bone loss, necessitating further research into long-term effects

The vegetable variety varies as menu changes